Literature DB >> 21468764

⁹⁰Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT).

Michael Wissmeyer1, Susanne Heinzer, Pietro Majno, Franz Buchegger, Habib Zaidi, Valentina Garibotto, Magalie Viallon, Christoph D Becker, Osman Ratib, Sylvain Terraz.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21468764     DOI： 10.1007/s00259-011-1792-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.

Authors:  Renaud Lhommel; Larry van Elmbt; Pierre Goffette; Marc Van den Eynde; François Jamar; Stanislas Pauwels; Stephan Walrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-27       Impact factor: 9.236

2.  Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT.

Authors:  Renaud Lhommel; Pierre Goffette; Marc Van den Eynde; François Jamar; Stanislas Pauwels; Jose I Bilbao; Stephan Walrand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-07-18       Impact factor: 9.236

3.  PET/CT for the assessment and quantification of (90)Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases.

Authors:  Matthias K Werner; Klaus Brechtel; Thomas Beyer; Helmut Dittmann; Christina Pfannenberg; Jürgen Kupferschläger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-09       Impact factor: 9.236

4.  Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept.

Authors:  Vanessa L Gates; Abdulredha A H Esmail; Karen Marshall; Stewart Spies; Riad Salem
Journal:  J Nucl Med       Date:  2010-12-13       Impact factor: 10.057
  4 in total
  9 in total

Review 1.  Clinical oncologic applications of PET/MRI: a new horizon.

Authors:  Sasan Partovi; Andres Kohan; Christian Rubbert; Jose Luis Vercher-Conejero; Chiara Gaeta; Roger Yuh; Lisa Zipp; Karin A Herrmann; Mark R Robbin; Zhenghong Lee; Raymond F Muzic; Peter Faulhaber; Pablo R Ros
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

Review 2.  Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer's perspective.

Authors:  Antonis Kalemis; Bénédicte M A Delattre; Susanne Heinzer
Journal:  MAGMA       Date:  2012-08-07       Impact factor: 2.310

3.  Feasibility of sequential PET/MRI using a state-of-the-art small animal PET and a 1 T benchtop MRI.

Authors:  Andreas Schmid; Jennifer Schmitz; Julia G Mannheim; Florian C Maier; Kerstin Fuchs; Hans F Wehrl; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

Review 4.  New paradigm for management of hepatocellular carcinoma by imaging.

Authors:  Ijin Joo; Byung Ihn Choi
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

5.  The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects.

Authors:  Hojjat Ahmadzadehfar; Marianne Muckle; Amir Sabet; Kai Wilhelm; Christiane Kuhl; Kim Biermann; Torjan Haslerud; Hans-Jürgen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

6.  Semi-Quantitative Analysis of Post-Transarterial Radioembolization (90)Y Microsphere Positron Emission Tomography Combined with Computed Tomography (PET/CT) Images in Advanced Liver Malignancy: Comparison With (99m)Tc Macroaggregated Albumin (MAA) Single Photon Emission Computed Tomography (SPECT).

Authors:  Seunghong Rhee; Sungeun Kim; Jaehyuk Cho; Jukyung Park; Jae Seon Eo; Soyeon Park; Eunsub Lee; Yun Hwan Kim; Jae-Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2015-09-14

Review 7.  Theranostic Imaging of Yttrium-90.

Authors:  Chadwick L Wright; Jun Zhang; Michael F Tweedle; Michael V Knopp; Nathan C Hall
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

8.  Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting.

Authors:  Yung-Hsiang Kao; Jeffrey D Steinberg; Young-Soon Tay; Gabriel Ky Lim; Jianhua Yan; David W Townsend; Angela Takano; Mark C Burgmans; Farah G Irani; Terence Kb Teo; Tow-Non Yeow; Apoorva Gogna; Richard Hg Lo; Kiang-Hiong Tay; Bien-Soo Tan; Pierce Kh Chow; Somanesan Satchithanantham; Andrew Eh Tan; David Ce Ng; Anthony Sw Goh
Journal:  EJNMMI Res       Date:  2013-07-25       Impact factor: 3.138

Review 9.  The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review.

Authors:  Andor F van den Hoven; Maarten L J Smits; Charlotte E N M Rosenbaum; Helena M Verkooijen; Maurice A A J van den Bosch; Marnix G E H Lam
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.